REG - Oxford Nanopore Tech - Publication of Annual Report and Notice of AGM

Oxford Nanopore TechnologiesAnnouncement

30/04/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240430:nRSd4822Ma&default-theme=true

RNS Number : 4822M  Oxford Nanopore Technologies plc  30 April 2024

30 April 2024

Oxford Nanopore Technologies plc

(the "Company")

Publication of 2023 Annual Report and Notice of Annual General Meeting

 

Oxford Nanopore Technologies plc (LSE:ONT), the company behind a new
generation of nanopore-based sequencing technology, today announces that it
has published its Annual Report and Accounts for the year ended 31 December
2023 and its Notice of Annual General Meeting 2024.

In compliance with Listing Rule 9.6.1, copies of the following documents have
been submitted to the National Storage Mechanism and will shortly be available
for inspection at:

https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism
(https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism)
 

·      Annual Report and Accounts for the year ended 31
December 2023 ("2023 ARA"); and

·      Notice of Annual General Meeting 2024 ("2024 AGM Notice").

Printed copies of the 2023 ARA and 2024 AGM Notice, together with the Form of
Proxy for use in connection with the 2024 Annual General Meeting, have been
posted to shareholders who have requested hard copies. Electronic copies of
the 2023 ARA and 2024 AGM Notice are available on the Investor Relations
section of the Company's website
at https://nanoporetech.com/about-us/investors
(https://nanoporetech.com/about-us/investors) .

The 2024 Annual General Meeting will be held at the Company's offices at
Gosling Building, Edmund Halley Road, Oxford Science Park, Oxford, OX4 4DQ at
1.00pm on Monday, 10 June 2024. Further details regarding the arrangements for
the 2024 Annual General Meeting can be found in the 2024 AGM Notice.

EXPLANATORY NOTE

For the purposes of complying with the Disclosure and Transparency Rules, the
2023 ARA being submitted to the National Storage Mechanism contains the
following regulated information in unedited form:

·      The principal risks and uncertainties facing the Company;

·      The Directors' responsibility statement made in respect of the
Financial Statements and Directors' Report contained in the 2023 ARA; and

·      A statement regarding related party transactions.

 ENDS 

For further information please contact:

Oxford Nanopore Technologies plc

Hannah Coote, Company Secretary

cosec@nanoporetech.com (mailto:cosec@nanoporetech.com)

 

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society
through enabling the analysis of anything, by anyone, anywhere. The Company
has developed a new generation of nanopore-based sensing technology that is
currently used for real-time, high-performance, accessible, and scalable
analysis of DNA and RNA. The technology is used in more than 120 countries,
to understand the biology of humans, plants, animals, bacteria, viruses and
environments as well as to understand diseases such as cancer.  Oxford
Nanopore's technology also has the potential to provide broad, high impact,
rapid insights in a number of areas including healthcare, food and
agriculture.

 

Oxford Nanopore devices sequence DNA and RNA directly and sequence short to
ultra-long fragments of DNA, for a truly comprehensive picture of the genome.
Data is streamed in real-time and can enable rapid insights.  The technology
is fully scalable - from pocket-sized to ultra-high throughput devices.

 

For more information please visit: www.nanoporetech.com
(http://www.nanoporetech.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOADBGDSRGDDGSC